GALACTOSIDE INHIBITORS FOR NEW USES

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

15300769

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided is a method for treatment or prevention of α-synucleinopathies in a mammalian subject, the method comprising administering a therapeutically effective amount of at least one composition to the subject, wherein the composition comprises a molecule for pharmacological modulation of galectin activity in a mammalian brain.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GALECTO BIOTECH AB2200 COPENHAGEN

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
DEIERBORG, Tomas Loddekopinge, SE 1 3
LEFFLER, Hakon Lund, SE 27 152
NILSSON, Ulf Lund, SE 114 736
SERRANO, Antonio Lund, SE 3 3

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation